The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | SHS | G01767105 | 407,489 | 13,213,000 | SH | SOLE | 13,213,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 43,350 | 8,500,000 | SH | SOLE | 8,500,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 56,427 | 3,926,700 | SH | SOLE | 3,926,700 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 181,963 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 207,266 | 2,967,300 | SH | SOLE | 2,967,300 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 110,520 | 6,614,000 | SH | SOLE | 6,614,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 214,053 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 40,542 | 4,299,297 | SH | SOLE | 4,299,297 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM NEW | 75915K200 | 1,279 | 1,851,851 | SH | SOLE | 1,851,851 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 11,086 | 707,010 | SH | SOLE | 707,010 | 0 | 0 | ||